IndraLab

Statements


| 2

reach
"USP54 upregulation in gefitinib-treated cells was associated with reduced EGFR ubiquitination, stabilizing EGFR and promoting cell survival."

reach
"Suppressing USP54 in gefitinib-resistant cells reversed gefitinib insensitivity, restoring EGFR ubiquitination and reducing resistance (Figs 3 and 4)."